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ABSTRACT
Glycolysis was reported to have a positive correlation with radioresistance. 
Our previous study found that the miR-33a functioned as a tumor suppressor in 
malignant melanoma by targeting hypoxia-inducible factor1-alpha (HIF-1α), a gene 
known to promote  glycolysis. However, the role of miR-33a-5p in radiosensitivity 
remains to be elucidated. We found that miR-33a-5p was downregulated in melanoma 
tissues and cells. Cell proliferation was downregulated after overexpression of miR-
33a-5p in WM451 cells, accompanied by a decreased level of glycolysis. In contrast, 
cell proliferation was upregulated after inhibition of miR-33a-5p in WM35 cells, 
accompanied by increased glycolysis. Overexpression of miR-33a-5p enhanced the 
sensitivity of melanoma cells to X-radiation by MTT assay, while downregulation of 
miR-33a-5p had the opposite effects. Finally, in vivo experiments with xenografts in 
nude mice confirmed that high expression of miR-33a-5p in  tumor cells increased 
radiosensitivity via inhibiting glycolysis. In conclusions, miR-33a-5p promotes 
radiosensitivity by negatively regulating glycolysis in melanoma.
INTRODUCTION
Malignant melanoma (MM), an aggressive skin 
malignancy, is the fifth most common malignant tumor in 
men and the seventh most common malignant tumor in 
women [1, 2]. Recent studies showed that the incidence 
of MM has increased by 3.1% per year [3]. Despite 
significant advances in early detection and treatment of 
MM, the prognosis of MM remains poor [4, 5]. Radiation 
is an important treatment modality for melanoma, 
therefore methods of increasing the radiosensitivity of 
melanoma cells are urgently needed.
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Increased glucose uptake and accumulation of 
lactate are common features of cancer cells. Lactate 
accumulation is considered an early event of malignant 
tumors and  promotes radiation resistance in solid 
tumors [6]. Sattler et al. [7] reported that tumor glycolysis 
is associated with inhibition of reactive oxygen species 
(ROS)-mediated fixation of DNA damage and induction of 
radioresistance. Aerobic glycolysis generates a chemically 
reduced milieu associated with the development of 
radioresistance in cancer cells, suggesting a significant 
therapeutic gain for combination with glycolysis inhibitors 
in radiotherapy [6, 8–10]. Furthermore, inhibitors of 
glycolysis, including 2-deoxy-d-glucose and oxamate (an 
inhibitor of lactate dehydrogenase A) [11, 12], obviously 
enhanced the sensitivity to radiotherapy. A combination 
of 2-deoxy-d-glucose and 6-aminonicotinamide (6-AN, 
an inhibitor of the pentose phosphate pathway) increased 
the radiosensitivity of neck cancer cells by activating 
ASK1/JNK/p38 MAPK signaling [13, 14]. Resistance 
to radiotherapy is considered to be an important factor 
limiting the efficacy of  melanoma treatment. Therefore, 
developing effective targeting agents of glycolysis may 
provide alternative therapeutic strategies for enhancing 
MM radiosensitivity.
MicroRNAs (miRNAs) regulate gene expression 
by inhibiting gene translation or facilitating mRNA 
degradation [15, 16]. In recent years, accumulating 
evidence has revealed that miRNAs negatively modulate 
a variety of genes pivotal for tumor development [17–20]. 
miR-33a has been found to play a key role of tumor 
suppressor in several human cancers. For instance, Du M 
et al. [21] showed that miR-33a suppressed proliferation 
of non-small-cell lung carcinoma cells via targeting 
oncogene METTL3 and Kuo et al. [22] found that miR-
33a functioned as a bone metastasis suppressor in lung 
cancer. In our previous study, we showed that miR-33a 
functions as a tumor suppressor by targeting HIF-1α in 
melanoma [23]. HIF-1α has been demonstrated to act as 
a key regulator in glycolysis [24]. However, the detailed 
functions of miR-33a-5p in MM cell radiosensitivity and 
the underlying molecular mechanism remains largely 
unclear. Not only that, related mechanisms of miRNAs 
negatively regulate glycolysis in melanoma radiotherapy 
has not been reported before. In the present study, we 
aimed to elucidate whether miR-33a-5p increases MM cell 
radiosensitivity by inhibiting glycolysis. Our data suggest 
that miR-33a-5p might be a promising molecular target for 
melanoma therapy.
RESULTS
Melanoma tissue and cell lines have lower miR-
33a-5p expression level
To explore the role of miR-33a-5p in MM, we first 
examined the expression level of miR-33a-5p in melanoma 
and nevus tissues by qRT-PCR and found that miR-33a-5p 
was significantly downregulated in carcinoma tissue 
compared with nevus tissue. Interestingly, the miR-33a-5p 
level in metastatic tissue specimens was much lower than 
that in primary tumor tissues (Figure 1A). We further 
examined the expression level of miR-33a-5p in three MM 
cell lines, WM35, WM451, and SK-MEL-1 and human 
melanocytes (HM). As shown in Figure 1B, the expression 
of miR-33a-5p was significantly downregulated in WM35, 
WM451 and SK-MEL-1 cells compared to HM cells. 
Based on these preliminary data, we chose WM35 and 
WM451 cells to further investigate the role of miR-33a-5p 
in MM in vitro.
miR-33a-5p inhibits the viability of melanoma 
cells
The expression of miR-33a-5p was low in WM35 
and WM451 cells, but much lower in WM451 cells, we 
transfected WM451 cells with pre-miR-33a-5p labeled 
green fluorescent protein plasmid and WM35 cells 
with anti-miR-33a-5p labeled green fluorescent protein 
plasmid. The transfection efficiency was evaluated 
by fluorescence microscopy and qRT-PCR. The green 
fluorescence representes the transfection efficiency of each 
plasmid. Over 80% of WM35 (Figure 1C) and WM451 
(Figure 1D) cells were stained in green fluorescence, 
which suggesting the transfection efficiency was satisfied. 
The results of qRT-PCR show that miR-33a-5p expression 
in WM35 cells was notably reduced after transfection with 
anti-miR-33a-5p plasmid (Figure 1E) whereas expression 
in WM451 cells was increased after transfection with 
pre-miR-33a-5p plasmid (Figure 1G), confirming that the 
transfections were successful.
Cell viability in each group was determined by MTT 
assay and found that cell proliferation was upregulated after 
inhibition of miR-33a-5p in WM35 cells (Figure 1F) but 
was  downregulated after overexpression of miR-33a-5p 
in WM451 cells (Figure 1H), suggesting that miR-33a-5p 
plays an inhibitory role in MM cell proliferation.
miR-33a-5p inhibits glycolysis in melanoma cells
As glycolysis functions as a promoter in 
radiosensitivity, we determined the glycolysis level in 
each group of cells. HIF-1 is a key regulator of cellular 
and systemic homeostatic responses to hypoxia through 
the activation of gene transcription, and is involved in 
energy metabolism, angiogenesis, and apoptosis [25, 26]. 
In our previous study, we confirmed that HIF-1α is a direct 
gene target of miR-33a in melanoma [22]. Furthermore, 
HIF-1α has been demonstrated to act as a key regulator 
in glycolysis, HIF-1α is the best-known transcriptional 
regulators controlling expression of glycolysis genes, 
such as HK1, HK2, and LDHA, whose expression levels 
are highly elevated in cancer cells [27]. As shown in 
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Figure 1: Expression of miR-33a-5p in MM tissue and cell lines. (A) miR-33a-5p expression was significantly downregulated in 
MM tissue samples compared with nevus by qRT-PCR. miR-33a-5p expression was also lower in metastatic tissue compared with primary 
tumor tissue. (B) qRT-PCR was performed to analyze the expression level of miR-33a-5p in three MM cell lines (WM35, WM451, and SK-
MEL-1) and human melanocytes (HM). (C) WM35 cells were transfected with normal control (NC) or anti-miR-33a-5p (anti-miR-33a-5p) 
lentivirus plasmids. Representative fluorescence microscopy (top) and bright field microscopic images (bottom) are shown in the left 
panel. (D) WM451 cells were transfected with NC (NC) or pre-miR-33a-5p (miR-33a-5p) lentivirus plasmids. Representative fluorescence 
microscopy (top) and bright field microscopic images (bottom) are shown in the right panel. (E) qRT-PCR analysis of miR-33a-5p 
expression relative to that in untreated WM35 cells (set as 1). (F) WM35 cell proliferation at the indicated time points determined by MTT 
assay. (G) qRT-PCR analysis of miR-33a-5p expression relative to that in non-treated WM451 cells (set as 1). (H) WM451 cell proliferation 
at the indicated time points determined by MTT assay. Scal bar: 50 μm. *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 2A, 2B, the expression of HIF-1α, HK1, HK2, 
and LDH-A was notably increased after inhibition of 
miR-33a-5p in WM35 cells, but reduced after miR-33a-
5p overexpression in WM451 cells. These results suggest 
that miR-33a-5p inhibits glycolysis in MM cells, and that 
HIF-1α is involved in this inhibitory activity.
Glucose uptake and LDH-A activity are main 
indicators of glucose metabolism. Lactic acid production, 
and ATP production were also measured to evaluate the 
glycolysis level, which are main products of glycolysis. As 
shown in Figure 3A–3D, lactic acid production, LDH-A 
activity, and ATP production were notably upregulated 
after inhibition of miR-33a-5p in WM35 cells, but all 
four parameters were downregulated after miR-33a-5p 
overexpression in WM451 cells. These findings further 
suggested that miR-33a-5p plays a suppressive role in the 
regulation of glycolysis in MM cells. 
HIF-1α is involved in miR-33a-5p-mediated 
glycolysis in melanoma cells
To further investigate whether HIF-1α acts as a 
downstream effecter in miR-33a-5p-mediated glycolysis in 
MM cells, we constructed 3 shRNA (small hairpin RNA) 
expression plasmids targeting HIF-1α, and then transfected 
into WM451 cells by lipofectamine methods. Western 
blotting was performed to detect the expression of HIF-1α 
protein (Figure 4A).Western blotting results revealed that 
the third shRNA sequence had the best inhibitory effect, 
sh3-HIF-1α plasmid was chose for further investigation. The 
cell proliferation after co-transfection with anti-miR-33a-5p 
and shHIF-1α plasmids or miR-33a-5p and HIF-1α plasmids 
were presented in supplementary materials. The results 
showed that HIF-1α significantly restored the inhibitory 
effect of miR-33a-5p (Supplementary Figure 1). WM35 
cells were transfected with anti-miR-33a-5p plasmid or 
co-transfected them with two lasmids expressing anti-miR-
33a-5p and sh3-HIF-1α, respectively. WM451 cells were 
transfected with pre-miR-33a-5p plasmid, or co-transfected 
them with two plasmids expressing pre-miR-33a-5p and 
HIF-1α, respectively. Glycolysis level was examined in each 
group. As shown in Figure 4B, downregulation of HIF-1α 
reversed the promoting effect of miR-33a-5p inhibition on 
glycolysis in WM35 cells, whereas upregulation of HIF-1α 
reversed the inhibitory effect of miR-33a-5p overexpression 
on glycolysis in WM451 cells.
Figure 2: miR-33a-5p targets the glycolysis signaling pathway in MM. (A) Western blot analysis of HIF-1α, HK1, HK2, and 
LDH-A protein expression in WM35 and WM451 cells. GAPDH protein expression was used as a control for input and normalization. (B) 
Quantitative graph showing the image intensity for WM35 and WM451 cells shown in A. *P < 0.05, **P < 0.01, ***P < 0.001.
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Glucose consumption, lactic acid production, 
LDH-A activity, and ATP production were measured to 
evaluate the glycolysis level. Figure 5A–5D shows that 
the glucose consumption, lactic acid production, LDH-A 
activity, and ATP production were notably reduced in 
WM35 cells after co-transfection with anti-miR-33a-5p 
and sh3-HIF-1α plasmids but were significantly 
upregulated in WM451cells after co-transfection 
with pre-miR-33a-5p and HIF-1α plasmids. These 
findingsconfirmed that miR-33a-5p plays an inhibitory 
role in glycolysis in MM cells by negatively regulating 
HIF-1α.
Figure 3: miR-33a-5p plays an inhibitory role in glycolysis in MM cells. (A) Glucose consumption was measured by microplate 
assay, with the value for non-treated cells set as 1. (B) Lactic acid production in WM35 and WM451 cells. Non-treated cells were used for 
normalization. (C) Activity of LDH-A was analyzed by activity gel assay. (D) ATP production was measured using a luciferin/luciferase 
assay.*P < 0.05, **P < 0.01.
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miR-33a-5p enhances radiosensitivity of 
melanoma cells to X-radiation
As indicated in Figure 6A, administration of 
increasing doses of radiation resulted in a dose-dependent 
downward trend in the cell survival rate of WM35 and 
WM451. In particular, the survival rate of WM35 cells 
was much higher in anti-miR-33a-5p group, while 
WM451 cells was lower in the miR-33a-5p group 
(P < 0.05). Considering the cell survival rate under 4 
Gy X-ray irradiation were ranged 50% to 60% in both 
untreated WM35 and WM451 cells, which could act as 
an ideal observation window  for further exploration. The 
MTT assay was performed to observe the cell survival rate 
at the indicated time points under 4-Gy X-ray irradiation. 
The results revealed a time-dependent downward trend 
in the cell survival rate. The survival rate of WM35 cells 
was higher after downregulation of miR-33a-5p, while 
WM451 cells was lower after overexpression of miR-
33a-5p (P < 0.05). These experimental data indicated 
that overexpression of miR-33a-5p might promote 
radiosensitivity of MM cells.
Figure 4: HIF-1α restores the inhibitory effect of miR-33a-5p on glycolysis. (A) Three shRNA expression plasmids targeting 
HIF-1α were transfected into WM451 cells, respectively. Western blotting results revealed that the third shRNA sequence had the best 
inhibitory effect. (B) WM35 cells were transfected with anti-miR-33a-5p plasmid, or co-transfected with anti-miR-33a-5p and sh-HIF-1α 
plasmids. WM451 cells were transfected with pre-miR-33a-5p plasmid, or co-transfected with pre-miR-33a-5p and HIF-1α plasmids. HIF-1α, 
HK1, HK2, and LDH-A protein expression was measured by western blotting. GAPDH protein expression was used as a control for input 
and normalization. *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 5: miR-33a-5p/HIF-1α axis plays an important role on glycolysis. (A) Glucose consumption was measured by microplate 
assay, with the value for non-treated cells set as 1. (B) Lactic acid production was detected in WM35 and WM451 cells. Untreated cells 
were used for normalization. (C) Activity of LDH-A was analyzed by activity gel assay. (D) ATP production was measured using a 
luciferin/luciferaseassay.*P < 0.05, **P < 0.01, ***P < 0.001.
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miR-33a-5p increases cell radiosensitivity by 
negatively regulating glycolysis in vivo
Nude mice were subcutaneously inoculated with 
WM451 cells, WM451 cells transfected with blank 
empty vector (NC), or WM451 cells transfected with 
pre-miR-33a-5p (miR-33a-5p) vector. The results 
showed that it took 12–14 days after tumor implantation 
for the tumor volume of each group reached 150 mm3. 
After tumor development, the mice were treated with 
irradiation at a total dose of 10 Gy. The growth curve 
of each group was showed at Figure 6B, which revealed 
that the tumor volume of nude mice in the miR-33a-5p 
group was significantly lower than that in unirradiated, 
WM451, and NC groups (P < 0.05).The average 
volume of the tumors (Figure 6C) in the unirradiated, 
WM451, and NC groups was 2400.83 ± 841.23, 979.15 
± 225.26 and 615.96 ± 257.78 mm3, respectively, which 
was notably higher than that in the miR-33a-5p group 
(246.07 ± 55.72 mm3). The average tumor mass (Figure 
6C) in the unirradiated, WM451, and NC groups was 
1.43 ± 0.39, 0.80 ± 0.14 and 0.55 ± 0.20 g, respectively, 
which was also higher than that in the miR-33a-5p group 
(0.24 ± 0.08 g). To analyze the relationship between 
radiosensitivity and glycolysis, western blot analysis 
was performed to measure the HIF-1α, HK1, HK2, and 
LDH-A protein expression levels in the xenograft tumor 
(Figure 6D). HIF-1α, HK1, HK2, and LDH-A proteins 
were significantly downregulated after overexpression 
of miR-33a-5p. Therefore, melanoma cells with high 
miR-33a-5p  expression level increased radiosensitivity 
accompanied by downregulation of glycolysis in vivo.
DISCUSSION
Increasing evidence indicates that microRNAs 
are associated with tumor radiosensitivity. Zhu et al. 
[28] found that downregulation of miR-21 enhanced 
radiosensitivity in nasopharyngeal carcinoma. Another 
study confirmed that miR-622 induced radioresistance 
by targeting Rb in colorectal cancer cells [29]. Liu et al. 
[30] reported that miR-18a increased radiosensitivity by 
promoting radiation-induced apoptosis in cervical cancer 
cells. In our previous study, we demonstrated that miR-33a 
functions as a tumor suppressor by targeting HIF-1α in 
melanoma cells [23]. The present study aim to investigate 
whether miR-33a-5p restores malanoma radioresistance.
We found that miR-33a-5p was significantly 
downregulated in melanoma tissue compared with nevus 
tissue. Interestingly, miR-33a-5p expression was much 
lower in metastatic tissue than in primary tissues. miR-
33a-5p expression was also notably reduced in MM cells. 
These results verified those reported previously by us. 
To further explore the inhibitory effect of miR-33a-5p 
in vitro, WM35 and WM451 cells were selected for 
subsequent experiments. MTT assays revealed that cell 
proliferation was upregulated after inhibition of miR-
33a-5p in WM35 cells, but notably downregulated after 
overexpression of miR-33a-5p in WM451 cells. Therefore, 
miR-33a-5p suppresses proliferation in MM cells.
Although less efficient than oxidative 
phosphorylation in the yield of adenosine triphosphate, 
glycolysis can more rapidly provide cancer cells with 
energy and the metabolic intermediates needed for 
macromolecular biosynthesis, conferring advantages 
to cancer cells under conditions of limited nutrient 
supply [31]. Therefore, targeting glycolysis seems to be an 
effective tumor therapy strategy. After showing that miR-
33a-5p could inhibit MM cell proliferation, we focused 
on the effect of miR-33a-5p on glycolysis in MM cells. 
The three key enzymes of glycolysis are HK1, HK2, and 
LDAH [32]. We found that the expression of HIF-1α, 
HK1, HK2, and LDH-A was increased after inhibition of 
miR-33a-5p in WM35 cells, but reduced after miR-33a-5p 
overexpression in WM451 cells. Moreover, knockdown of 
miR-33a-5p promoted glycolysis, as measured by glucose 
consumption, lactic acid production, LDH-A activity, and 
ATP production, whereas upregulation of miR-33a-5p 
inhibited glycolysis in MM cells. In our previous study, we 
confirmed that miR-33a-5p functions as tumor suppressor 
mainly via directly binding HIF-1α 3’UTR [23]. HIF-1α 
is one of hypoxic-related genes helps tumor cells adapting 
to the low nutrient and oxygen microenviroment. There 
is an obvious positive correlation between HIF-1α and 
glycolysis during tumorigenesis [33, 34]. miR-33a-5p 
plays an inhibitory role in glycolysis in melanoma, 
suggesting HIF-1α may  involve in this activity. We 
further confirmed that upregulation of HIF-1α reversed 
the inhibitory effect of miR-33a-5p overexpression on 
glycolysis in WM451 cells, whereas downregulation of 
HIF-1α reversed the promoting effect of miR-33a-5p 
inhibition on glycolysis in WM35 cells. HK1/HK2 
as well as LDAH was proved upregulated by HIF-1α 
overexpression, while was inhibited by knock-down 
HIF-1α, which were basically in accord with previous 
studies [35]. HK2 is considered as a downstream of HIF-
1α in fermentation, which acts as a rate-limiting enzyme 
and involves in one irreversible step of glycolysis [36]. 
The results mentioned above suggesting that miR-33a-5p 
represses glycolysis mainly via inhibition of HIF-1α in 
melanoma.
Radioresistance is one of major problems 
encountered in cancer therapy. Previous studies have 
strongly suggested that glycolysis leads to radiation 
resistance of cancer cells [37]. HIF-1α has recently been 
shown being participated in tumor glycometabolism. 
Jiang S et al. [38] found that HIF-1α was upregulated by 
miR-21 in radioresistant non-small cell lung cancer cells. 
Considering miR-33a-5p acts as an upstream factor of 
HIF-1α,  MTT assays  were performed to measure the cell 
survival rate of MM cells under X-ray irradiation. The 
results indicated that the radiosensitivity of MM cells was 
Oncotarget83668www.impactjournals.com/oncotarget
enhanced by overexpression of miR-33a-5p. Accordingly, 
we suggest that the radiosensitizing effects of miR-33a-5p 
in MM cells in vitro may be mediated by suppression of 
glycolysis. WM35 cells are lowly tumorigenic and even 
non-tumorigenic in nude mice [39], Therefore only WM451 
cells were performed to explorethe antitumor effect 
of miR-33a-5p. Finally, in vivo xenograft experiments 
revealed that the tumor burden of melanoma was reduced 
by radiotherapy, and high expression of miR-33a-5p in 
MM cells increased radiosensitization accompanied by 
downregulation of glycolysis. These findings indicating that 
miR-33a-5p functions as a tumor suppressor by inhibiting 
HIF-1α-mediated glycolysis (Figure 7). However, there are 
some questions remain to be clarify. Understanding why 
these cells under-expressed miR-33a-5p is the next step in 
our further education.
Figure 6: miR-33a-5p increases cell radiosensitivity by negatively regulating glycolysis in MM. (A) MTT assay was 
performed to measure the cell survival rate of WM35 and WM451 cells at 8 days under 0, 2, 4, 6, and 8 Gy irradiation. The survival rate 
was significantly lower in the miR-33a-5p group compared with the non-transfected and control groups. MTT assay was also performed 
to observe the cell survival rate at the indicated time points under 4 Gy X-ray irradiation. (B) Growth curve of nude mice with different 
levels of miR-33a-5p expression. Day 0 means the day of injection of tumor cells. Arrows indicated the day radiotherapy began for mice in 
WM451, NC, and miR-33a-5p groups. (C) Representative images of subcutaneous tumors at day 30. Tumor volume and weight of WM451 
xenografts in the unirradiated, WM451, NC, and miR-33a-5p groups. The results were analyzed using one-way ANOVA. (D) Western 
blotting of HIF-1α, HK1, HK2, and LDH-A protein expression in WM451 xenografts. GAPDH protein expression was used as a control 
for input and normalization. IR: irradiation. *P < 0.05, **P < 0.01, ***P < 0.001.
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In summary, we suggest that miR-33a-5p promotes 
radiosensitivity by negatively regulating glycolysis in 
MM cells. Therefore, targeting the miR-33a-5p/glycolysis 
pathway may provide a new direction for radiotherapy of 
melanoma.
MATERIALS AND METHODS
Reagents
Glucose-Dulbecco’s modified Eagle’s medium 
(DMEM), fetal bovine serum (FBS), Trizol reagent, 
miRNA reverse transcription kit, and Lipofectamine 2000 
were purchased from Life Technologies (Waltham, MA). 
BCA protein assay kits were purchased from Beyotime 
(Haimen, China). Pre-miR-33a-5p lentivirus plasmid, 
anti-miR-5p lentivirus plasmid, HIF-1α overexpressing 
plasmid, and HIF-1α shRNA plasmid were purchased 
from DingGuoChangShengBiotech (Beijing, China). 
Sequences of the insert in plasmids were listed in 
Supplementary Table 1. miRNA qRT-PCR Detection 
Kit was purchased from GeneCopoeia, Rockville, MD, 
USA. RevertAid™ H Minus First Strand cDNA Synthesis 
Kit was purchased from Fermentas. MTT was purchased 
from Biosharp (Hefei, Anhui, China). The Power SYBR 
Green kit was purchased from TOYOBO (Osaka, Japan). 
The glucose assay kit, lactate assay kit, and LDH activity 
assay kit were from Biovision (Milpitas, CA). The ATP 
assay Kit was from Beyotime Biotechnology (Shanghai). 
Mouse anti-HIF-1α monoclonal antibody, mouse anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
monoclonal antibody, and rabbit anti-mouse secondary 
antibody were purchased from Abcam (Cambridge, UK) 
and anti-lactate dehydrogenase A (LDH-A) antibody was 
from Epitomics (Burlingame, CA).
Samples
Twenty melanoma and match nevus tissues were 
collected by the Department of Pathology at the Second 
Xiangya Hospital and Third Xiangya Hospital, Central 
South University between 2004 and 2014, following 
informed consent from each of the patients and approval 
by the Ethics Committee of Third Xiangya Hospital, 
Central South University. None of the melanoma patients 
received chemotherapy or radiotherapy before surgery. 
All specimens were fixed in 10% neutral formalin and 
embedded in paraffin.
Figure 7: Reported and potential mechanisms for the regulation of the radiosensetivity by miR-33a-5p in MM. miR-
33a-5p inhibits the process of glycolysis mainly via negatively regulating HIF-1α, a closely related gene of glycolysis. Glycolysis products 
such as pyruvate and lactate played important roles in radioresistance. miR-33a-5p increased MM cell radiosensetivity account for down-
regulation glycolysis level.
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Cell culture
Human malignant melanoma cell lines A375, 
WM35, WM451, and SK-MEL-1 were obtained from 
the Cell Bank of Central South University, Changsha, 
China. Primary human melanocytes (HM) were purchased 
from Shanghai XinYu Biological Technology Co., 
Ltd (Shanghai, China).Cells were cultured in DMEM 
supplemented with 10% FBS at 37°C in a humidified 
incubator containing 5% CO2.
Transfection
Transfection was performed using Lipofectamine 2000 
in accordance with the manufacturer’s instructions. In brief, 
for functional analysis MM cells were transfected with the pre-
miR-33a-5p lentivirus plasmid, anti-miR-33a-5p lentivirus 
plasmid, HIF-1α overex pressing plasmid, or HIF-1α 
shRNA plasmid.
Real-time RT-PCR assay
Total RNA was extracted with Trizol agent in 
accordance with the manufacturer’s instructions. For 
the analysis of miRNA expression, a miRNA reverse 
transcription kit was used to convert RNA into cDNA 
according to the manufacturer’s protocol. Real-time PCR 
was performed using a miRNA qRT-PCR Detection Kit 
on an ABI 7500 thermocycler (Life Technologies). The 
U6 gene was used as an endogenous control. For the 
analysis of mRNA expression, Revert Aid™ H Minus First 
Strand cDNA Synthesis Kit was used to convert RNA into 
cDNA and real-time PCR was performed using a Power 
SYBR Green kit on an ABI 7500 thermocycler. GAPDH 
was used as an endogenous control. For both mRNA and 
miRNA, the relative expression was analyzed by the 
2−ΔΔCt method. The primers used were as follows: miR-
33a-5p, 5ʹ-GATCCTCAGTGCATTGTAGTTGC-3′ and 
reverse 5′-CTCTGTCTCTCGTCTTGTTGGTAT-3′; U6, 
5′-ATTGGAACGATACAGAGAAGATT-3′ and reverse 
5′-GGAACGCTTCACGAATTTG-3′.
Cell viability assay
For all groups, 10,000 cells per well were plated in 
a 96-well plate. After treatment, the plates were incubated 
for 0, 24, 48, 72,96 or 120 h at 37°C, 5% CO2. To assess 
cell viability, the MTT assay was performed according 
to the manufacturer’s manual. Briefly, 10 μl of 5 mg/
ml MTT reagent in PBS was added to each well and 
incubated for 4 h at 37°C, 5% CO2. The supernatant was 
removed and 100 μl of DMSO was added. Absorbance 
was detected at 450 nm with a Microplate Reader (Bio-
Rad, USA). Each assay was performed in triplicate wells 
and repeated three times.
Western blotting
Protein was extracted from the indicated cells using 
RIPA lysis buffer. Protein assay reagents (Beyotime) 
were used to measure the protein concentration. A total 
of 60 μg of protein was separated with 12% SDS-PAGE 
and transferred to a PVDF membrane, which was blocked 
in 5% nonfat dried milk in PBS at room temperature for 
2 h. The membrane was incubated with mouse anti-HIF-
1α antibody or mouse anti-GAPDH monoclonal antibody 
overnight at 4°C and then with goat anti-mouse secondary 
antibody for 2 h. Enhanced chemiluminescence reagent 
was used to detect the signal on the membrane. Data were 
analyzed by densitometry using Image-Pro plus software 
6.0 and normalized to GAPDH expression. The western 
blot experiments were repeated at least three times.
Measurement of glycolysis
Glucose consumption was detected using a glucose 
assay kit according to the manufacturer’s protocol. The 
absorbance at 570 nm was measured with a plate reader 
(Thermo Multiskan MK3 spectrophotometer; Thermo 
Fisher Scientific, Waltham, MA). Lactate levels in the 
culture media were determined using a lactate assay kit 
according to the manufacturer’s protocol. 
Total intracellular LDH activity was examined using 
an LDH activity assay kit according to the manufacturer’s 
instructions. The results were normalized to the total 
protein concentration. Briefly, 2 × 105 cells per well were 
plated in a 24-well plate for 48 h. The cells were collected, 
washed, and protein was extracted for measurement of 
LDH-A activity.
Cellular ATP was measured using a luciferin/
luciferase assay kit. Cells were permeabilized prior 
to the addition of luciferin substrate and luciferase. 
Bioluminescence was assessed on an LUMATLB9507 
luminometer (EG&G Berthold, Bad Wildbad, Germany) 
and cellular ATP content (nmol/mg) was determined using 
a curve for the luminescence of standard dilutions of ATP. 
ATP content was normalized to protein content.
Radiation studies
A Varian Truebeam linear accelerator (Varian, 
USA) was used for X-ray irradiation. Cells at a density 
of 3 × 103 cells/well were irradiated with different doses 
of X-rays (100 cm, 4 Gy/min) after 48 h of transfection. 
Animal experimentation was performed according to 
NIH Animal Care guidelines, and the entire experiment 
was approved by the Ethics Committee of Third Xiangya 
Hospital, Central South University. Male Balb/c Nu/nu 
mice aged approximately 4–6 weeks were obtained from 
Third Xiangya Hospital of Central South University and 
2 × 106 WM451 cells were subcutaneously injected into 
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the flanks of the mice. When the tumor volume reached 
150 mm3, the mice were treated with irradiation at a total 
dose of 10 Gy for 5 consecutive days. Nude mice were 
sacrificed 30 days after tumor implantation, and tumor 
volume and weight were measured. Tumor volume was 
calculated using the formula V (cm3) = 0.5 × a × b2,where 
a is the maximum long diameter and b is the maximum 
transverse diameter.
Statistical analysis
All experiments were repeated at least three times, 
and the results are expressed as the mean ± SD (n = 3). 
SPSS18.0 software (SPSS, Inc., Chicago, IL, USA) was 
used to perform statistical analysis. Statistical analysis 
of differences was performed by one-way analysis of 
variance (ANOVA). *P < 0.05 was considered statistically 
significant.
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